#LCSM Chat Topic 12/15: Holiday Open House
It’s the end of the year, and everyone’s busy. For our final 2016 #LCSM Chat (no chat on 12/29), we decided to just have an informal conversation about lung cancer. Our December 15 #LCSM Chat topic (at 5pm Pacific Time, 8 pm Eastern Time) will be “#LCSM Chat Holiday Open House,” and we’ll talk about whatever we want. Moderator @JFreemanDaily might think of some questions to ask. 😉
Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. A link to the chat transcript will be available after the chat on our Schedules and Transcripts page.
We look forward to chatting with you!
#LCSM Chat topic 12/1: #LCAM Wrap-Up
November and Lung Cancer Awareness Month are both ending soon. During our December 1, 2016 #LCSM Chat (at 8 pm Eastern Time), we will discuss the various #LCAM campaigns and initiatives and assess what worked, and what didn’t.
Before the chat, please think about the lung cancer advocacy campaigns and events you observed during #LCAM, as well as the social media activity they generated and audiences they reached. You can find links to some of these activities on the 11/03 #LCSM Chat blog post.
During the chat, your moderator @JFreemanDaily will pose the following questions:
- T1: What #LCAM efforts worked well? Which attracted the most attention or reached new audiences?
- T2: Did you visit @IASLC’s lcam.org during #LCAM? What did you think of the site? The patient & caregiver stories?
- T3: What sorts of #LCAM posts did you share or promote on social media? Which of them generated the most social media buzz?
- T4: Which #LCAM campaigns or activities did you like most 2016?
- T5: What would you suggest the #lungcancer community do again or do differently for #LCAM 2017?
Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. A link to the chat transcript will be available after the chat on our Schedules and Transcripts page.
We look forward to chatting with you!
#LCSM Chat topic 11/17– FB Live Q&A with NCI on Immunotherapy and Clinical Trials
For Lung Cancer Awareness Month, the National Cancer Institute (NCI) is once again partnering with #LCSM Chat for a special event.
During the first half of our November 17 tweetchat, which starts at the usual 8 PM Eastern time (5 PM Pacific), the NCI’s Dr. Shakun Malik (head of thoracic oncology therapeutics) and Janet Freeman-Daily (lung cancer patient/activist and founding member of #LCSM Chat) will have a 30-minute Facebook Live question and answer session on the topic of “Immunotherapy for Lung Cancer: New Research and Clinical Trials.” The Facebook Live event will be visible on the National Cancer Institute’s Facebook page.
Concurrent with the Facebook Live event, #LCSM Chat will conduct their regularly scheduled Twitter chat 11/17 starting at 8 PM. For the first 30 minutes of the chat, topics will parallel the Facebook Live discussion. After the Facebook Live event concludes, the second half of the tweetchat will focus on resources for accessing clinical trials. Deana Hendrickson (@LungCancerFaces) will moderate the first half of the chat, and Janet Freeman-Daily (@JFreemanDaily) will join her in moderating the second half of the chat.
Please feel free to ask questions for Dr. Malik or Ms. Freeman-Daily on the NCI Facebook page or during the #LCSM Twitter chat.
First half chat topics will mirror those in the Facebook Live event:
- T1: What is the role immunotherapies play in lung cancer research and treatment?
- T2: What is new in the Lung-MAP clinical trial?
- T3: What is new in the ALCHEMIST clinical trial?
- T4: What is the role of genetic testing in screening and qualifying for lung cancer clinical trials?
- T5: What resources are available to help patients and caregivers investigate clinical trials?
Second half chat topics will continue discussing clinical trials:
- T6: What tools and services are available to help patients and caregivers investigate lung cancer clinical trials?
- T7: What considerations affect your decision to join a clinical trial?
Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. A link to the chat transcript and a Storify summary will be available within a few days on our Schedules and Transcripts page.
We look forward to chatting with you about lung cancer immunotherapy and clinical trials on November 17.
#LCSM 
You must be logged in to post a comment.